Wolverine Trading, LLC Recursion Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.92 - $8.6 $455,840 - $662,200
77,000 Added 91.45%
161,200 $1.06 Million
Q2 2024

Aug 14, 2024
BUY
$7.35 - $10.05 $83,055 - $113,565
11,300 Added 15.5%
84,200 $631,000
Q1 2024

May 15, 2024
BUY
$9.13 - $15.52 $390,764 - $664,256
42,800 Added 142.19%
72,900 $726,000
Q4 2023

Feb 14, 2024
BUY
$5.09 - $10.79 $65,661 - $139,191
12,900 Added 75.0%
30,100 $296,000
Q3 2023

Nov 15, 2023
BUY
$6.59 - $15.86 $113,348 - $272,792
17,200 New
17,200 $131,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email